Breast Cancer

A newly-diagnosed patient talks about her experience of being diagnosed with breast cancer amidst the COVID-19 pandemic.

Based on objective response rate and duration of response measured in a phase 2 study, the Food and Drug Administration approved Trodelvy, an antibody-drug conjugate, for use in previously treated patients with metastatic triple-negative breast cancer.

Traditionally, it is the younger generations that become caregivers first. But cancer alters the best-laid plans.

Stay connected during these challenging times and keep up with all the news and updates from Susan G. Kommen Greater NYC by signing up for our latest newsletter!

The Food and Drug Administration approved Tukysa, which is indicated for use with two other drugs after patients have completed treatment with prior therapies targeting the protein HER2.

The COVID-19 Pandemic has drastically altered the landscape for both oncology professionals and patients with cancer. For oncology nurse Patricia Jakel, the pandemic has altered both her professional and personal lives as an oncology professional and patient.

The COVID-19 pandemic has forced many to shelter in place causing a rare form of isolation. One that has even challenged a group of people used to challenges, patients with cancer and survivors.

From legendary singer-songwriter John Prine passing away due to coronavirus complications to one patient’s doctor seeing her through her scan when her family couldn’t be there due to COVID-19 restrictions, here’s what is making the headlines in the cancer space this week.

Decades after being tested for hereditary risk, two women — who had the same doctor — discovered they got the wrong results.

A guy with breast cancer has a simple suggestion for coping with stress.

One survivor on "New Normals" and living through "apocalyptic" times that reveal who we really are.

One survivor reflects on how quarantine amid the coronavirus outbreak is impacting her life and reflects on current events.

Making sense of a difficult situation feels like wading through quicksand. The more we struggle, the deeper we get. However, cancer survivors know how to face the fear of uncertainty even the uncertainty of the COVID-19 pandemic.

“Often you think we’re the victim, but there’s a lot that you can do to be your own advocate and participate in your healing,” says stage four metastatic breast cancer thriver Nalie Agustin.

While patients with cancer and survivors face extra risk due to the COVID-19 pandemic, they are more adept at handling the uncertainty and fear than one may think.

In the time of this pandemic, we're all in this together and need to give back where we can.

Genetic testing offers a care team a wealth of knowledge to help them craft treatments, but it also can help match patients to clinical trials for potentially better outcomes.

In the face of the COVID-19 pandemic patients with cancer who are considered to have weakened immune systems need to have a special emphasis placed on their care.

Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.

Having the right understanding and information of a patient’s genetics can not only help treat cancer but also help prevent it.

Response minimizes exposure, frees up needed health capacity to deal with COVID-19.

Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.

Understanding biomarkers specific to breast cancer can guide treatment plans and help families with a history of the disease take preventive measures.

As CDK 4/6 inhibitors become a bigger part of the treatment of breast cancer, CURE® sat down with clinical nurse specialist Patricia Jakel to discuss the essentials about the drug.